Management and manufacturing the safety product via a bio plant with the advanced production facilities
The manufacturing plant for the product of ‘Botulinum Toxin’, PROTOX Research In
Construction of the bio plant
Construction of the new bio plant compliance with GMP guidelines capable of manufacturing and managing ‘Botulinum Toxin’ with a surface area of about 6,280m2 in pharmaceutical complex, Hyangnam.